<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H3EC7037F976F41CDBC73DF9CBA633E89" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 2827 IH: Part D Beneficiary Appeals Fairness Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2013-07-25</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 2827</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130725">July 25, 2013</action-date>
			<action-desc><sponsor name-id="J000288">Mr. Johnson of
			 Georgia</sponsor> (for himself, <cosponsor name-id="J000255">Mr.
			 Jones</cosponsor>, <cosponsor name-id="M001180">Mr. McKinley</cosponsor>, and
			 <cosponsor name-id="B001259">Mr. Braley of Iowa</cosponsor>) introduced the
			 following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in
			 addition to the Committee on <committee-name committee-id="HWM00">Ways and
			 Means</committee-name>, for a period to be subsequently determined by the
			 Speaker, in each case for consideration of such provisions as fall within the
			 jurisdiction of the committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XVIII of the Social Security Act to allow
		  for fair application of the exceptions process for drugs in tiers in
		  formularies in prescription drug plans under Medicare part D.</official-title>
	</form>
	<legis-body id="HA4A7EBC9767E4E3FA5BB1578867ADB1C" style="OLC">
		<section id="HB0B9794123E647EF8A848EF915A0CCE3" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Part D Beneficiary Appeals Fairness
			 Act</short-title></quote>.</text>
		</section><section id="H78955C165D754CB482A31456E2EAECD9"><enum>2.</enum><header>Fair exceptions
			 process for drug in tiers under Medicare part D</header><text display-inline="no-display-inline">Section 1860D–4(g)(2) of the Social Security
			 Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-103">42 U.S.C. 1395w–103(g)(2)</external-xref>) is amended—</text>
			<paragraph id="HE34AE511619D4CBBA01233F1D6854C39"><enum>(1)</enum><text display-inline="yes-display-inline">in the first sentence—</text>
				<subparagraph id="H35A2C536B8B34D83B63A9F8EA70F5C93"><enum>(A)</enum><text>by striking
			 <quote>for tiered cost-sharing for drugs included within a formulary
			 and</quote> and inserting <quote>for any tiered cost-sharing structure within a
			 formulary (including a structure that</quote>; and</text>
				</subparagraph><subparagraph id="HEF4975BAD6944B77A01726F09F8E65EB"><enum>(B)</enum><text>by inserting
			 <quote>, or provides for different co-payment or coinsurance amounts for drugs
			 in different tiers included within the formulary)</quote> before <quote>, a
			 part D eligible individual</quote>;</text>
				</subparagraph></paragraph><paragraph id="H2FA8B25AD29C40F7BF7D6C2112CD900B"><enum>(2)</enum><text>in the second
			 sentence, by inserting <quote>in any plan formulary</quote> before <quote>could
			 be covered</quote>; and</text>
			</paragraph><paragraph id="HC37003709732483E8443A480844ABB21"><enum>(3)</enum><text>by inserting the
			 following before the last sentence: <quote>In no case may the Secretary allow a
			 PDP sponsor to make any formulary tier of the tiered cost-sharing structure
			 (including a formulary tier used for very high cost or unique items) ineligible
			 for lower-cost sharing through an exception under this
			 paragraph.</quote>.</text>
			</paragraph></section></legis-body>
</bill>


